Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01056198 · ClinicalTrials.gov registry record · Phase 4

Santyl vs. Sharp Debridement of Diabetic Foot Wounds

A Phase 4 study, sponsored by Healthpoint.

Completed
Registry status
Phase 4
Development phase
48
Enrollment target

NCT01056198 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01056198, a Phase 4 study, has completed, sponsored by Healthpoint.

COMPLETED
Registry status
Phase 4
Development phase
48 participants
Enrollment target

Study Summary

This study tests two different approaches to the removal of dead tissue from the surface of a wound.

Interventions

  • PROCEDURE Control
  • DRUG Santyl

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2010-02
Est. Completion 2011-11
Phase Phase 4

Sponsor

Healthpoint

25 total trials

What the Registry Record Tells You About NCT01056198

The ClinicalTrials.gov registry entry for NCT01056198 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT01056198 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01056198 about?

NCT01056198 is a clinical study titled "Santyl vs. Sharp Debridement of Diabetic Foot Wounds". This study tests two different approaches to the removal of dead tissue from the surface of a wound.

What is the current status of trial NCT01056198?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2010-02. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01056198?

The interventions under investigation include: Control (PROCEDURE), Santyl (DRUG).

Who is sponsoring clinical trial NCT01056198?

This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.